Insider Trading & Ownership of Fred Hassan

Location
Boca Raton, FL
Summary
The estimated net worth of Fred Hassan is at least $9,665,530 dollars as of 16 Mar 2026. Fred Hassan is the Director of PRECIGEN, INC. and owns shares of PRECIGEN, INC. (PGEN) stock worth about $5.89M. Fred Hassan is the Director of Cocrystal Pharma, Inc. and owns shares of Cocrystal Pharma, Inc. (COCP) stock worth about $2.92M. Fred Hassan is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $850.2K.
Signature
/s/ Fred Hassan, by Donald P. Lehr, as attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Fred Hassan and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Fred Hassan has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $9,665,530.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: PRECIGEN, INC. ($5,892,952).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Fred Hassan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PGEN PRECIGEN, INC. Director $5,892,952 13 Mar 2026
COCP Cocrystal Pharma, Inc. Director $2,922,384 09 Jan 2026
BBIO BridgeBio Pharma, Inc. Director $850,194 20 Jun 2025
EYPT EyePoint, Inc. Director 02 Jan 2026
RXDX Prometheus Biosciences, Inc. Director 16 Jun 2023

Insider Transactions Reported by Fred Hassan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .